- Rising cost of innovation in pharmaceuticals
- Reforms in healthcare systems to provide affordable care
- Emergence of disruptive new players in the industry
- Aging population and rise of chronic diseases
- Persistent unmet medical needs
- Climate change, biodiversity loss, and environmental damage
- Growing expectations from companies on non-financial issues
- Patients taking more control of their healthcare
- Covid-19 pandemic and its impact on operations and supply chains
Les Laboratoires Servier
Greenhouse gas emissions & sustainability report data
In its 2020 reporting, Les Laboratoires Servier disclosed greenhouse gas emissions of 1.0M tCO2e/year (2016-2017). By scope: Scope 1: 6% of total emissions; Scope 2: 5% of total emissions; Scope 3: 89% of total emissions. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.
GHG Emissions
1.0M tCO2e/year (2016-2017)
2020
Water Usage
621.7K m3/year (2019-2020)
2020
Energy Use
199.6M KWh/year (2019-2020)
2020
📊 Emissions by Scope (2020)
| Scope | What it covers | Reported value |
|---|---|---|
| Scope 1 | Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions). | 6% of total emissions |
| Scope 2 | Indirect emissions from purchased electricity, steam, heat and cooling. | 5% of total emissions |
| Scope 3 | Other indirect emissions across the value chain (purchased goods, business travel, use of sold products, etc.). | 89% of total emissions |
New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.
✅ Reported Environmental Achievements
- 6 industrial sites, as well as the Group’s headquarters, with ISO 14001 and/or ISO 50001 certification
- 1,013,679 tons of CO2 emitted (in comparison with reference year 2015/2016), i.e. 1.2 kg of CO2/box of medicine
- Arklow site in Ireland sent zero waste to landfill since 2013
- 60.93% of waste from the Group’s industrial R&D sites was recycled in 2019/2020
- Energy usage of production and R&D sites in France remained constant (down slightly by 1.25%) in the 2019/2020 financial year, even though production increased
- Amount of water used at production and R&D sites in France fell by 4.58%
- Offset 15,000 tons of CO2 equivalent through reforestation and geothermal power plant projects
- Servier Research and Development Institute in Paris-Saclay aiming for BiodiverCity® accreditation
🎯 Climate & Sustainability Targets
📅 Medium-term
- -25% Greenhouse Gas emissions by 2030
🌱 ESG Focus Areas
Product safety and qualityAnti-counterfeitingEcodesignGlobal approach to health careBusiness ethicsResponsible purchasingEthics and transparency of clinical trialsResponsible marketing and promotionStakeholder engagementHealth and safety at workEmployee well-beingDiversity, Inclusion and equal opportunitiesManagerial practicesAccess to health careLocal development and community engagementClimate change and responsible use of resourcesEffluent and waste management